Portal de Periódicos da CAPES

Epidermal Calmodulin and Skin Disease

1985; Wiley; Volume: 24; Issue: 8 Linguagem: Inglês

10.1111/j.1365-4362.1985.tb05830.x

1365-4632

P.C.M. van de Kerkhof, P.E.J. van Erp,

Melanoma and MAPK Pathways

International Journal of DermatologyVolume 24, Issue 8 p. 507-508 Epidermal Calmodulin and Skin Disease P. C. M. van de Kerkhof M.D., Corresponding Author P. C. M. van de Kerkhof M.D. Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, NetherlandsAddress for correspondence: Peter v.d. Kerkhof, M.D., Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, Netherlands.Search for more papers by this authorP. E. J. van Erp B.Sc., P. E. J. van Erp B.Sc. Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, NetherlandsSearch for more papers by this author P. C. M. van de Kerkhof M.D., Corresponding Author P. C. M. van de Kerkhof M.D. Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, NetherlandsAddress for correspondence: Peter v.d. Kerkhof, M.D., Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, Netherlands.Search for more papers by this authorP. E. J. van Erp B.Sc., P. E. J. van Erp B.Sc. Department of Dermatology, University of Nijmegen Faculty of Medicine, Nijmegen, NetherlandsSearch for more papers by this author First published: October 1985 https://doi.org/10.1111/j.1365-4362.1985.tb05830.xCitations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Voorhees JJ, Duell EA. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. Arch Dermatol. 1971; 104: 352–358. CASPubMedWeb of Science®Google Scholar 2 Klee CB, Crouch TH, Richman PG. Calmodulin. Ann Rev Biochem. 1980; 49: 489–515. 10.1146/annurev.bi.49.070180.002421 CASPubMedWeb of Science®Google Scholar 3 Fairley JA, Hogan VA, Marcelo CL. Epidermal keratinoyte calmodulin: shifts in hyperproliferative systems (abstract). J Invest Dermatol. 1983; 80: 335. Web of Science®Google Scholar 4 Van de Kerkhof PCM, Van Erp PEJ. Calmodulin levels are grossly elevated in the psoriatic lesion. Br J Dermatol. 1983; 108: 217–218. 10.1111/j.1365-2133.1983.tb00066.x PubMedWeb of Science®Google Scholar 5 Tucker WFG, MacNeil S, Bleeken SS, et al. Biologically active calmodulin levels are elevated in both involved and uninvolved epidermis in psoriasis. J Invest Dermatol. 1984; 82: 298–299. 10.1111/1523-1747.ep12260398 CASPubMedWeb of Science®Google Scholar 6 Van de Kerkhof PCM, Van Erp PEJ, Mier PD, et al. Calmodulin levels in psoriasis (abstract). J Invest Dermatol. 1984; 82: 562. Google Scholar Citing Literature Volume24, Issue8October 1985Pages 507-508 ReferencesRelatedInformation